produce unintended potentially harmful effects remains largely unexamined increasing number untested unauthorized stem cell treatments threaten people buy researchers hoping conduct clinical trials promising stem cell medicine far fda approved stem cell treatment people blood cancer leukemia increasing number unapproved stem cell treatments clearly violate fda regulations technically legal approval july 2012 example u.s. district court brought fda colorado based regenerative sciences regulate company stem cell treatments joint injuries unapproved biological drug product decision hinged constitutes minimal manipulation cells lab injected patients treatment fda won right regulate stem cells grown modified lab weeks returned patients regenerative sciences treatments patients stem